WallStreetZenWallStreetZen

NASDAQ: PASG
Passage Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Passage Bio earnings were -$37.7M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest PASG earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$7.6M, down 41.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PASG reported annual earnings of -$45.5M, with -29.7% growth.

PASG earnings history

Current Revenue
$0.0
Current Earnings
-$37.7M
Current Profit Margin
0%

PASG Return on Equity

Current Company
-150.9%
Current Industry
-146.1%
Current Market
6.2%
PASG's Return on Equity (-150.9%)... subscribe to Premium to read more.
High Return on Equity Performance

PASG Return on Assets

Current Company
-59.8%
Current Industry
-12.8%
PASG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PASG announces earnings.

PASG Return on Capital Employed

Current Company
-230.32%
Current Industry
-8.9%
PASG's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PASG vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PASG-$37.02M-$37.68MN/A-$11.85
COCP-$8.77M-$8.83MN/A-$0.73
ICU-$11.87M-$11.90MN/A-$3.86
GTBP-$47.54M-$58.42MN/A-$14.83
NCELN/A-$8.30MN/A-$2.16
View Top Biotech Stocks

Passage Bio Earnings Reports & History FAQ

What were Passage Bio's earnings last quarter?

Passage Bio (NASDAQ: PASG) reported Q1 2026 earnings per share (EPS) of -$2.36, up 51.54% year over year. Total PASG earnings for the quarter were -$7.56 million. In the same quarter last year, Passage Bio's earnings per share (EPS) was -$4.87.

If you're new to stock investing, here's how to buy Passage Bio stock.

Is Passage Bio profitable or losing money?

As of the last Passage Bio earnings report, Passage Bio is currently losing money. Passage Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$37.68 million, a 40.63% decrease year over year.

What was PASG's earnings growth in the past year?

As of Passage Bio's earnings date in Q2 2026, Passage Bio's earnings has grown year over year. PASG earnings in the past year totalled -$37.68 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.